Figure 3

Comparison of survival curves in pancreatic cancer. a. Comparison of survival curves between Group A (2001–2005) and Group B (2006–2010) in patients with pancreatic cancer (n = 1,082). MST, median survival time. b. Comparison of survival curves between Group A (2001–2005) and Group B (2006–2010) in patients with pancreatic cancer who chose chemotherapy or best supportive care (n = 895). MST, median survival time. c. Comparison of survival curves between patients with pancreatic cancer who chose chemotherapy and best supportive care in Group A (2001–2005) (n = 342). MST, median survival time. d. Comparison of survival curves between patients with pancreatic cancer who chose chemotherapy and best supportive care in Group B (2006–2010) (n = 553). MST, median survival time. e. Comparison of survival curves between Group A (2001–2005) and Group B (2006–2010) in patients who had pancreatic cancer and underwent surgical resection (n = 187). MST, median survival time.